Sandbox: HS

Jump to navigation Jump to search


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Differential diagnosis

Abbreviations: COPD= Chronic obstructive pulmonary disease,

Causes of cyanosis Disease Cyanosis Clinical manifestations/association Diagnosis Additional

findings

Symptoms Signs
Peripheral Central Dyspnea Fever Chest pain Clubbing Peripheral edema Auscultation Lab Findings Imaging Gold standard
Respiratory Airway

disorder

Croup + +
Epiglottitis +
Foreign body aspiration + +
Airway trauma + + ±
Disease Peripheral Central Dyspnea Fever Chest pain Clubbing Peripheral edema Auscultation Lab Findings Imaging Gold standard Additional findings
Parenchymal

disorder

Pulmonary embolism
  • ABGs
  • D-dimer
  • Dyspnea
  • Tachycardia
  • Pleuretic chest pain
Pneumonia
  • ABGs
  • Leukocytosis
  • Pancytopenia
  • CXR
  • CT chest
  • Bronchoscopy
  • Shortness of breath
  • Cough
Asthma

(Late)

+
Cystic fibrosis ± ±
COPD

(Emphysema)

± +
Empyema ± + Chest X-ray
  • Pleural opacity
  • Localization of effusion
Physical examination
Disease Peripheral Central Dyspnea Fever Chest pain Clubbing Peripheral edema Auscultation Lab Findings Imaging Gold standard Additional findings
Chest

wall

disorders

Flail chest ±
Pneumothorax ±
Hemothorax + ±
Cardiovascular Congenital

heart diseases

Disease Peripheral Central Dyspnea Fever Chest pain Clubbing Peripheral edema Auscultation Lab Findings Imaging Gold standard Additional findings

Atrioventricular canal defect

+ +
Ebstein anomaly
Hypoplastic left heart syndrome
Pulmonary atresia
Tetralogy of Fallot
Pulmonic stenosis
Total anomalous pulmonary venous drainage
Transposition of the great vessels
Truncus arteriosus
Disease Peripheral Central Dyspnea Fever Chest pain Clubbing Peripheral edema Auscultation Lab Findings Imaging Gold standard Additional findings
Heart failure + + ± +
Valvular heart disease +
Myocardial infarction
Hematologic Methemoglobinemia
Polycythemia
Central Nervous system Peripheral Central Dyspnea Fever Chest pain Clubbing Peripheral edema Auscultation Lab Findings Imaging Gold standard Additional findings
Coma
Seizures
Head trauma
Breath holding spells
Miscellaneous Shock
Smoke inhalation + + +
Toxic gases + + + + ±
Cold exposure
  • Fingerstick glucose (Hyperglycemia)
  • Electrocardiogram (ECG) may show J wave, sinus bradycardia and prolongation of all ECG intervals.
  • Serum electrolytes (including potassium and calcium)
  • BUN and creatinine
  • Serum hemoglobin, white blood cell, and platelet counts ( Raised HCT due to volume contraction)
  • Coagulation profile (clotting factors impairment)
  • Serum lactate ( lactic acidosis)
  • Creatine kinase (Rhabdomylosis)
  • Arterial blood gas
  • CXR
* Mild hypothermia: core temperature 32 to 35°C ; patient presents with confusion, tachycardia, and increased shivering.
  • Moderate hypothermia: 28 to 32°C patient presents with lethargy, bradycardia and arrhythmia and decreased shivering.
  • Severe hypothermia: below 28°C patient presents with coma, hypotension, arrhythmia, pulmonary edema, and rigidity.
Drugs†

Classification

Acute liver failure may be classified on the basis of the duration of the symptoms between the onset of jaundice to the onset of encephalopathy. The different classification systems based on the number of weeks from the appearance of jaundice to the encephalopathy are:

Classification system Duration
O’Grady System
  • Hyperacute (0 - 1 week)
  • Acute ( From 2nd week - 4 weeks)
  • Subacute ( From 4th week - 12 weeks)
Bernuau System
  • Fulminant ( 0 - 2 weeks)
  • Subfulminant ( 2 weeks - 12 weeks)
Japanese System
  • Fulminant (0 - 8 weeks)
    • Acute ( 0 - 1.5 weeks)
    • Subacute ( 1.5 weeks - 8 weeks)
  • Late-Onset ( 8 weeks - 12 weeks)

The 1993 classification defines three subcategories based on the severity and duration of the acute liver failure. [1] The importance of this method of classification is that the pace of the disease evolution strongly influences prognosis. The underlying etiology causing the development of acute liver failure is the other significant determinant in regards to prognosis.[2] This classification system is based upon the duration between onset of jaundice to onset of encephalopathy.

Classification Time
Hyperacute 1 week
Acute 1 week - 1 month
Subacute 1 week - 3 months

Acute liver failure can also be classified into fulminant or subfulminant. Both of these forms have a poor prognosis. It is based upon the duration between onset of hepatic illness, to the development of encephalopathy.[3]

Classification Time
Fulminant within 2 months
Subfulminant within 2 months to 6 months

O’Grady System

The classification of encephalopathy according to the O’Grady system is as follows.[4]

Hyperacute

Hyperacute encephalopathy is an encephalopathy that occurs within 7 days of onset of jaundice.

Acute

Acute encephalopathy is an encephalopathy that occurs within an interval of 8 to 28 days from onset of jaundice.

Subacute

Subacute encephalopathy is an encephalopathy that occurs within 5 to 12 weeks of onset of jaundice.

Bernuau System

The classification of encephalopathy according to the Bernuau system is as follows.[5]

Fulminant

Fulminant encephalopathy is an encephalopathy that occurs within 2 weeks of onset of jaundice.

Subfulminant

Subfulminant encephalopathy is an encephalopathy that occurs within an interval of 2 to 12 weeks from onset of jaundice.

Japanese System

The classification of encephalopathy according to the Bernuau system is as follows.[6]

Fulminant

Fulminant encephalopathy is an encephalopathy that occurs within 8 weeks of onset of jaundice.

Late-Onset

Late onset encephalopathy is an encephalopathy that occurs within an interval of 8 to 24 weeks from onset of jaundice.

Acute

Acute encephalopathy is an encephalopathy that occurs within 10 days of onset of jaundice

Subacute

Subacute encephalopathy is an encephalopathy that occurs within an interval of 11 to 56 days from onset of jaundice

  1. O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet 1993;342:273-5. PMID 8101303.
  2. O'Grady JG (2005). "Acute liver failure". Postgraduate medical journal. 81 (953): 148–54. doi:10.1136/pgmj.2004.026005. PMID 15749789.
  3. Williams R (1996). "Classification, etiology, and considerations of outcome in acute liver failure". Seminars in Liver Disease. 16 (4): 343–8. doi:10.1055/s-2007-1007247. PMID 9027947. Retrieved 2012-10-26. Unknown parameter |month= ignored (help)
  4. O'Grady, JG.; Schalm, SW.; Williams, R. (1993). "Acute liver failure: redefining the syndromes". Lancet. 342 (8866): 273–5. PMID 8101303. Unknown parameter |month= ignored (help)
  5. Bernuau, J.; Rueff, B.; Benhamou, JP. (1986). "Fulminant and subfulminant liver failure: definitions and causes". Semin Liver Dis. 6 (2): 97–106. doi:10.1055/s-2008-1040593. PMID 3529410. Unknown parameter |month= ignored (help)
  6. Mochida, S.; Nakayama, N.; Matsui, A.; Nagoshi, S.; Fujiwara, K. (2008). "Re-evaluation of the Guideline published by the Acute Liver Failure Study Group of Japan in 1996 to determine the indications of liver transplantation in patients with fulminant hepatitis". Hepatol Res. 38 (10): 970–9. doi:10.1111/j.1872-034X.2008.00368.x. PMID 18462374. Unknown parameter |month= ignored (help)